Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20194 results available
- November 20192 results available
- October 20192 results available
- September 20193 results available
- July 20192 results available
- June 20192 results available
- May 20194 results available
- April 20192 results available
- March 20192 results available
- January 20191 results available
Displaying 16 - 24 of 24 items.
Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion
AlertHealth professional risk communication | 2019-05-30
Health Canada suspends Allergan's licences for its Biocell breast implants after safety review concludes an increased risk of cancer
AlertInformation update | 2019-05-28
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
AlertHealth professional risk communication | 2019-05-21
Health Canada is advising Canadians about the potential health risks associated with unauthorized cell therapy treatments such as stem cell therapy
AlertInformation update | 2019-05-15
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30